Share on StockTwits

Optos Plc (LON:OPTS)‘s stock had its “buy” rating reiterated by analysts at Panmure Gordon in a research report issued to clients and investors on Thursday. They currently have a GBX 235 ($4.02) price target on the stock. Panmure Gordon’s price objective indicates a potential upside of 27.55% from the company’s current price.

OPTS has been the subject of a number of other recent research reports. Analysts at N+1 Singer reiterated a “buy” rating on shares of Optos Plc in a research note on Thursday. They now have a GBX 260 ($4.45) price target on the stock. Separately, analysts at Numis Securities Ltd reiterated a “buy” rating on shares of Optos Plc in a research note on Thursday, May 15th. They now have a GBX 300 ($5.14) price target on the stock. Finally, analysts at Investec reiterated a “reduce” rating on shares of Optos Plc in a research note on Thursday, May 15th. One equities research analyst has rated the stock with a sell rating and seven have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus target price of GBX 252.67 ($4.33).

Shares of Optos Plc (LON:OPTS) traded up 6.29% on Thursday, hitting GBX 186.00. The stock had a trading volume of 28,204 shares. Optos Plc has a one year low of GBX 120.00 and a one year high of GBX 214.50. The stock’s 50-day moving average is GBX 177.4 and its 200-day moving average is GBX 184.. The company’s market cap is £134.5 million.

Optos Plc is a retinal imaging company. The Company’s medical devices produce ultra-widefield, high resolution digital images of approximately 82% of the retina in a single capture.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.